J Korean Surg Soc. 2010 Jun;78(6):385-389. Korean.
Published online Jun 07, 2010.
Copyright © 2010 The Korean Surgical Society
Original Article

Antimicrobial Prophylaxis Using a 2nd Generation Cephalosporin after Laparoscopic Colorectal Resection: A Randomized Trial of 1-day vs. 3-day

Han Deok Kwak, M.D., Dong Jin Choi, M.D., Si Uk Woo, M.D., Jin Kim, M.D., Jun Won Um, M.D.,1 and Seon Hahn Kim, M.D.
    • Department of Surgery, Korea University Anam Hospital, Seoul, Korea.
    • 1Department of Surgery, Korea University Ansan Hospital, Ansan, Korea.
Received December 11, 2009; Accepted March 08, 2010.

Abstract

Purpose

We performed this study to compare 1-day group using a 2nd generation cephalsporin with 3-day group for evaluating hospital acquired infection.

Methods

The patients underwent laparoscopic colorectal surgery at Korea University Medical Center Anam Hospital, from August, 2007 to June, 2008. They were randomly allocated to 2 groups: 1-day or 3-day group. A 2nd generation cephalosporin was administered within 1 hour before surgery with 12-hour intervals. In cases of suspected infection, further studies were done to identify infection.

Results

The study included 154 patients (1-day group - 78, vs. 3-day group - 76). No differences were noted between the 2 groups in age, body mass index, smoking, diabetes mellitus, corticosteroid-use were noted. Gender (P=0.011) and mean operative time (P=0.047) between the 2 groups were different. The preventive rates of infection were 87.18% in the 1-day group compared with 82.89% in the 3-day group (P=0.456).

Conclusion

Our prospective randomized control study concluded that there were no differences between the 1-day and 3-day group in hospital acquired infection. We could come to the conclusion that 1-day antimicrobial agent in laparoscopic colorectal surgery would be adequate in preventing infection.

Keywords
Antimicrobial prophylaxis; Monotherapy; Laparoscopic colorectal surgery; Surgical site infection; Hospital acquired infection

Tables

Table 1
Clinical characteristics

Table 2
Indications for surgery and selected operative details

Table 3
Postoperative variables

Table 4
Hospital acquired infection and results of 1-day vs 3-day group

References

    1. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001;29:404–421.
    1. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005;189:395–404.
    1. Bratzler DW, Houck PM, Richards C, Steele L, Dellinger EP, Fry DE, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005;140:174–182.
    1. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992;326:281–286.
    1. Stone HH, Hooper CA, Kolb LD, Geheber CE, Dawkins EJ. Antibiotic prophylaxis in gastric, biliary and colonic surgery. Ann Surg 1976;184:443–452.
    1. Korean Society of ColoproctologyRecommendations of antibiotic use of selective colorectal resection [Internet]. Seoul: Korean Society of Coloproctology; 2007.
      Available from: http://www.colon.or.kr.
      Sep 5.
    1. Sakong P, Lee JS, Lee EJ, Ko KP, Kim CH, Kim Y, et al. Association between the pattern of prophylactic antibiotic use and surgical site infection rate for major surgeries in Korea. J Prev Med Public Health 2009;42:12–20.
    1. Kim YS, Lee SH, Ahn BK, Baek SU. Dual therapy and triple therapy of prophylactic antibiotics after elective colorectal surgery: a comparative study. J Korean Soc Coloproctol 2009;25:14–19.
    1. Barie PS, Eachempati SR. Surgical site infections. Surg Clin North Am 2005;85:1115–1135.
    1. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999;20:250–280.
    1. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606–608.
    1. Kow L, Toouli J, Brookman J, McDonald PJ. Comparison of cefotaxime plus metronidazole versus cefoxitin for prevention of wound infection after abdominal surgery. World J Surg 1995;19:680–686.
    1. Itani KM, Wilson SE, Awad SS, Jensen EH, Finn TS, Abramson MA. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 2006;355:2640–2651.
    1. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003;163:972–978.
    1. American Society of Health-System Pharmacists. ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. Am J Health Syst Pharm 1999;56:1839–1888.
    1. Fujita S, Saito N, Yamada T, Takii Y, Kondo K, Ohue M, et al. Randomized, multicenter trial of antibiotic prophylaxis in elective colorectal surgery: single dose vs 3 doses of a second-generation cephalosporin without metronidazole and oral antibiotics. Arch Surg 2007;142:657–661.
    1. Basse L, Thorbol JE, Lossl K, Kehlet H. Colonic surgery with accelerated rehabilitation or conventional care. Dis Colon Rectum 2004;47:271–277.
    1. Evans RS, Pestotnik SL, Burke JP, Gardner RM, Larsen RA, Classen DC. Reducing the duration of prophylactic antibiotic use through computer monitoring of surgical patients. DICP 1990;24:351–354.

Metrics
Share
Tables

1 / 4

PERMALINK